NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









i-Seq Biotechnology

i-Seq Biotechnology

Private
Mobile, AlabamaHealthcare & Life Scienceshttps://i-seq.com/

Last Round

Grant

Jun 9, 2026

Total Funding Raised

$10,000

Company Overview

i-Seq Biotechnology is a biotechnology company that develops novel, broad-spectrum vaccines and therapeutics against infectious disease pathogens.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

CRISPRi-Seqvaccine developmentinfectious diseasedrug discoverybacterial virulence factorsbroad-spectrum vaccinetherapeutic targetspreclinical biotechantibiotic resistancebiotech startupdrug pipelinewet-labgenomics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

i-Seq Biotechnology Comps

Public and private peers based on sector, stage, and business model.

i-Seq Biotechnology comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

i-Seq Biotechnology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 9, 2026
SeedOct 15, 2024
View all Funding Rounds

Key People

Founding team and executive leadership

Michael Artinger

Chief Executive Officer Chair, Board of Directors Co-Founder

Founding Team

i-Seq Biotechnology Investors

Notable investors and investment history

i-Seq Biotechnology investors
InvestorRounds
INCATEGrant
VIC Investor NetworkSeed
View all Investors

i-Seq Biotechnology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

i-Seq Biotechnology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about i-Seq Biotechnology's valuation, stock price, and market status.

Firmographic Details

HeadquartersMobile, Alabama
Employee Range3
Year Founded2024
Last FundingJun 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.